1. P404: PROGNOSTIC IMPACT OF CEBPA-MUTATIONAL SUBGROUPS IN ADULT AML – RESULTS OF A LARGE METAANALYSIS IN MORE THAN 1000 CEBPA-MUTANT PATIENTS. (23rd June 2022) Authors: Georgi, J.-A.; Stasik, S.; Kramer, M.; Röllig, C.; Haferlach, T.; Valk, P.; Linch, D.; Herold, T.; Duployez, N.; Taube, F.; Platzbecker, U.; Serve, H.; Baldus, C.; Müller-Tidow, C.; Haferlach, C.; Meggendorfer, M.; Koch, S.; Boertjes, E. L.; Hills, R. K.; Burnett, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S162: SOMATIC GENETIC LANDSCAPE IN GATA2 DEFICIENCY PATIENTS. (23rd June 2022) Authors: Largeaud, L.; Collin, M.; Monselet, N.; Vergez, F.; Larcher, L.; Hirsch, P.; Duployez, N.; Bustamante, J.; Bellanné-Chantelot, C.; Donadieu, J.; Sicre de Fontbrune, F.; Nolla, M.; Fieschi, C.; Delhommeau, F.; Delabesse, E.; Pasquet, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CURRENT STATUS OF MOLECULAR ANALYSIS OF MRD IN MDS. (May 2023) Authors: Duployez, N. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): PRATICAL USE OF MONOCYTE SUBSET BY FLOW CYTOMETRY AND SEQUENCING IN DIAGNOSIS AND PROGNOSIS OF CLINICAL RELEVANT MONOCYTOSIS. (May 2023) Authors: Podvin, B.; Dumezy, F.; Boudry, A.; Pascal, L.; Fournier, E.; Berthon, C.; Roumier, C.; Guermouche, H.; Carpentier, B.; Soenen, V.; Herlem, J.; Willaume, A.; Fenwarth, L.; Roche-Lestienne, C.; Charpentier, A.; Quesnel, B.; Preudhomme, C.; Duployez, N. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA. (May 2023) Authors: Quang, V. Tran; Podvin, B.; Desterke, C.; Tarfi, S.; Barathon, Q.; Bouchra, B.; Freynet, N.; Parinet, V.; Leclerc, M.; Sébastien, M.; Solary, E.; Selimoglu-Buet, D.; Duployez, N.; Wagner-Ballon, O.; Sloma, I. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗